Generated by AI
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing Alpha DaRT, a targeted alpha-radiation platform designed for the treatment of solid tumors. The company’s core work centers on research, clinical development, and commercialization of localized cancer therapies that deliver alpha particles directly inside tumor tissue while limiting exposure to surrounding healthy tissue. Alpha Tau Medical Ltd. is active in a range of oncology indications, including skin, oral, pancreatic, prostate, lung, liver, breast, and brain cancers, reflecting the broad potential use of its technology across difficult-to-treat solid tumors. Headquartered in Jerusalem, Israel, the company operates as a medical technology business serving the oncology sector and is centered on advancing precision radiation approaches for cancer care.
WebsiteKiryat HaMada St. 5
Jerusalem, 9777605
Israel
The latest articles about DRTS.
- All eight treated brain cancer patients in the trial remain alive as of November 11, 2026; median overall survival has not been reached, with a median follow-up of 6.9 months from trial enrollment (range 3.1 to 11.6 months) in the six patients who have reached response assessment - - All six patients who have reached response assessment achieved a RANO objective response as their best overall response, with five patients showing complete responses (83.3%), including a previously reported stabl
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Investors talking about DRTS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.